insomnia ohsu
TRANSCRIPT
Insomnia
OHSU Travel Free CME
August 12, 2020
Jonathan Emens, MD, FAASM, DFAPAAssociate Professor, Departments of Psychiatry and Internal Medicine
Oregon Health & Science University
Deputy Clinical Director, Mental Health & Clinical Neurosciences
Portland VA Medical Center
Portland, OR
OHSU
Insomnia
• Definitions
• Etiology
• Morbidity/Co-Morbidity
• Diagnosis
• Treatment
– Pharmacologic
– Behavioral
• Case
OHSU
Definitions: DSM-V• Insomnia Disorder (307.42)
• Dissatisfaction with the amount or quality of sleep along
with:
– Difficulty falling asleep
– Difficulty staying asleep
– Early-morning awakening
• “Causes clinically significant distress or impairment”
• Happens at least 3 nights per week
• Has lasted at least 3 months
• Not better or adequately explained by:
– Inadequate opportunity for sleep
– Another sleep disorder (e.g., sleep apnea, narcolepsy or a
circadian rhythm sleep disorder)
– Substance use
– Other mental or medical disorders
OHSU
Etiology
From: Kryger, Roth, Dement, eds., Principles and Practice of Sleep Medicine, 2011
Also see: Reimann et al. Sleep Med Rev 2010;14: 19-31
OHSU
Etiology: Evidence for
physiological hyperarousal
Reimann et al. Sleep Med Rev 2010;14: 19-31
Bonnet and Arand Sleep Med Rev 2010;14: 9-15
• Hyperarousal Insomnia?
• Genetic component? Higher monozygotic twin concordance
• People with insomnia don’t show evidence of sleep deprivation on multiple sleep latency test (MSLT, nap study)
• Increased high frequency EEG in non-REM sleep
• Increased metabolic rate (sleep & wake)
• Increased cortisol levels
• Increased sympathetic/decreased parasympathetic activity during sleep (HRV)
OHSU
Etiology: Evidence for
physiological hyperarousal
Reimann et al. Sleep Med Rev 2010;14: 19-31
Bonnet and Arand Sleep Med Rev 2010;14: 9-15
• Hyperarousal Insomnia?
• Genetic component? Higher monozygotic twin concordance
• People with insomnia don’t show evidence of sleep deprivation on multiple sleep latency test (MSLT, nap study)
• Increased high frequency EEG in non-REM sleep
• Increased metabolic rate (sleep & wake)
• Increased cortisol levels
• Increased sympathetic/decreased parasympathetic activity during sleep (HRV)
OHSU
Morbidity/Co-Morbidity• Psychiatric: prevalence of any psychiatric disorder is
2-3x greater in insomniacs, depression prevalence is 4x greater
• Decreased quality of life
• Increased accidents and decreased productivity
• Increased risk of:– Hypertension
– Diabetes
– Metabolic syndrome (> 3: hyperglycemia, hypertriglyceridemia, increased waist circumference, HTN)
– Myocardial infarction
– DepressionRoth T, Journal of Clinical Sleep Medicine 2007; 3:S7-S10.
Vgontzas et al., Sleep 2009; 32: 491-497.
Vgontzas et al., Diabetes Care 2009; 32:1980-1985.
Troxel et al., Sleep 2010; 33: 1633-1640.
Laugsand et al., Circulation 2011; 124: 2073-2081
Laugsand et al., Euro Heart J 2013; 124: 2073-2081
Breslau N, Biol Psychiatry 1996;39:411-418
Chang PP, Am J Epidemiol 1997;146:105-114
Weissman MM, Gen Hosp Psych 1997;19:245-250
OHSU
Morbidity/Co-Morbidity:
Depression
Weissman MM, Gen Hosp Psych. 1997;19:245-250.
OHSU
Morbidity/Co-Morbidity:
Depression
Weissman MM, Gen Hosp Psych. 1997;19:245-250.
OHSU
Morbidity/Co-Morbidity:
Depression
Cho HJ, Am J Psych. 2008;165: 1543-1550.
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Vgontzas et al., Sleep 2009; 32: 491-497.
Morbidity/Co-Morbidity:
Hypertension
OHSU
Diagnosis
OHSU
Diagnosis
• Made on the basis of diagnostic criteria
• Overnight sleep study only indicated for the diagnosis of another sleep disorder (e.g., sleep apnea or periodic limb movement disorder)
• What is useful? History/ROS, questionnaires, sleep diaries and wrist actigraphy
• Difficult in practice to differentiate between what were once called “primary” and “secondary” insomnias
OHSU
Diagnosis
• History of the Insomnia– When did it begin?
– Any known precipitants?
– Usual questions:• Timing (number of episodes & frequency)
• Duration
• Severity (e.g., ISI questionnaire),
• Any known modifying factors (e.g., stress or pain)?OHSU
Diagnosis
OHSU
Diagnosis
• Characterizing the Insomnia– Routine prior to trying to go to sleep
– Range of bedtimes and wake times (including days off)
– Bedtime routine (e.g., lights out right away?)
– How long does it take to fall asleep, number & duration of awakenings, duration of sleep, duration of time in bed
• Sleep latency
• Wake after sleep onset (WASO)
• Total Sleep Time (TST)
• Sleep Efficiency (SE) = percentage of sleep opportunity that is sleep
– What do they do when awake (e.g., stay in bed?)
OHSU
Diagnosis
• Characterizing the Insomnia (cont.)– Excessive mental activity? Worry or sadness
(even if they don’t meet GAD or MDD criteria)?
– Worry about sleep itself? Excessive efforts to fall asleep?
– Any problems with noise, temperature, light or safety?
– Does pain or tinnitus disturb sleep?
– Do they nap? Can they nap? Do they try to catch up on sleep after a bad night?
– Do they ever sleep well (e.g., away from their usual environment)?
OHSU
Diagnosis
• Sleep ROS:– Snoring, witnessed apneas, choking/gasping, reflux,
nocturia, morning headaches, morning dry mouth, daytime somnolence, or napping? - Sleep Apnea
– Nightmares? Dream enactment? – PTSD vs trauma associated sleep disorder vs REM Behavior disorder
– Bruxism?
– Sleepwalking or sleep talking? - Slow-wave sleep parasomnias
– “Do you have a restless, nervous, tingly, or creepy-crawly feeling in your legs that disrupts your ability to fall or stay asleep?” - Restless Legs Syndrome
– Kicking or twitching during sleep? - Periodic LimbMovement Disorder
– Sleep paralysis, hypnogognic/hypnopomic hallucinations,cataplexy, & daytime somnolence? - Narcolepsy
OHSU
Diagnosis
• The history or characterization of insomnia aswell as the sleep ROS may seem obvious
• However, they impact treatment even if there isn’t complete diagnostic clarityOHSU
Treatment
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
Treatment: Patient Education
OHSU
Your Brainwaves During Different Parts of Sleep
Awake (eyes closed):
N1 (light sleep):
N2:
N3 (deeper sleep):
REM (tend to dream):
• Sleep is a dynamic &
active process
• Different parts (stages)
of sleep based on the
EEG
• The concept of local
sleep
Vyazovsky et al., Nature 2011; 472: 443-447
Nobili et al., Prog Brain Res 2012; 199: 219-232
Treatment: Patient Education
OHSU
24-Hour Body Clock
From: http://www.nigms.nih.gov/Education/Pages/Factsheet_CircadianRhythms.aspx
There is a clock in your brain (20,000 nerve cells). The Clock is reset by light through the eyes. It
tells your body what time it is. It tries to wake you up when it thinks it is daytime and it tries to make
you sleepy when it thinks it is nighttime.
Sleep Drive
You build up more sleep drive the longer you are awake. You have less sleep drive the longer you
are asleep. You can think of it like the gas that powers a car: you “fuel up” during the day by building
up sleep drive and you “burn up” sleep drive when you sleep.
• There are multiple
areas in the brain
involved in generating
sleep & wakefulness
• The “two-process”
model of sleep: the 24-
hour body clock and
homeostatic sleep
drive
Treatment: Patient Education
OHSU
What is Jet Lag?
(or)
Why light is important for sleep
Portland, OR:
20 22 00 02 04 06 08 10 12
New York, NY:
23 01 03 05 07 09 11 13 15
Treatment: Patient Education
OHSU
What is Jet Lag?
(or)
Why light is important for sleep
Portland, OR:
20 22 00 02 04 06 08 10 12
New York, NY:
23 01 03 05 07 09 11 13 15
Treatment: Patient Education
OHSU
Sleep in hunter-gatherers
12 14 16 18 20 22 00 02 04 06 08 10 12
Time
Black = when they were moving
Red = awake
Yellow = light level
Dark Blue = main sleep period
Yetish et al., Curr Biol. 2015;25: 1-7
• Sleep under “natural” light/dark conditions
• Cultural ideas about sleep
Treatment: Patient Education
OHSU
Treatment: Patient Education
OHSU
Treatment: Patient Education
OHSU
From: Kryger, Roth, Dement, eds., Principles and Practice of Sleep Medicine, 2011
Treatment: Patient Education
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
Winkleman NEJM 2015;373:1437-1444
More detailed review: Buysee JAMA 2013;309: 706-716
Treatment: Pharmacologic
Antihistamines
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
Treatment
• Treat underlying Medical or Psychiatric
Condition (insomnia symptoms can remain)
• Improve sleep hygiene (limited data on
efficacy)
• Change environment
• Cognitive-Behavioral Therapy for Insomnia
(CBT-I)
• Pharmacologic
• Light and melatonin (“chronotherapy”)
OHSU
• Progressive relaxation
• EMG biofeedback
• Guided imagery
• Stimulus control therapy: in bed only when sleepy, bed/bedroom is for sleep and sex only, & get out of bed when unable to sleep
• Bed Restriction: fixed waketime, change bedtime by 15 minutes if sleep efficiency >90% in the last week
• Regular sleep schedule and light/dark schedule
• Requires the use of a sleep diary
Treatment: Behavioral
Morin CM, et al. Sleep 2006;29:1398-1414
OHSU
• Progressive relaxation
• EMG biofeedback
• Guided imagery
• Stimulus control therapy: in bed only when sleepy, bed/bedroom is for sleep and sex only, & get out of bed when unable to sleep
• Bed Restriction: fixed waketime, change bedtime by 15 minutes if sleep efficiency >90% in the last week
• Regular sleep schedule and light/dark schedule
• Requires the use of a sleep diary
Treatment: Behavioral
Morin CM, et al. Sleep 2006;29:1398-1414
OHSU
Buysee JAMA 2013;309: 706-716
Treatment: Behavioral
OHSU
Treatment: Behavioral
OHSU
Treatment: Behavioral
OHSU
Treatment: Behavioral
Free online CBT-I:
https://www.veterantraining.va.gov/insomnia/
OHSU
Smith MT et al., Am J Psych. 2002;159:5-11
Buysee JAMA 2013;309: 706-716
Krystal AD et al., Sleep. 2008;31:79-90.
Glass et al. J Clin Psychopharm 2008; 28: 182-188
Krystal, et al. Sleep 2010; 33:1553-61
Michelson et al. Lancet Neurol 2014; 13: 461-471
Morin CM, et al. JAMA 1999;281:991-9
Jacobs GD, et al. Arch Intern Med 2004;164:1888-1896
Treatment: Efficacy
(Pharmacologic &
Behavioral)Variable Average Improvement (consider study
length and how measured – PSG vs. diary)
Sleep Latency ~15 to 30 minutes faster
Number of Awakenings ~ one less awakening
Total Sleep Time ~20-60+ minutes more sleepOHSU
Treatment: Comparisons
• Similar efficacy pharmocologic vs. cognitive-behavioral
treatments in several studies
• 8 weeks of CBT vs. temazepam vs. combined treatment.
Morin CM, et al. JAMA 1999;281:991-9
Jacobs GD, et al. Arch Intern Med 2004;164:1888-1896
Morin CM, et al. Sleep 2006;29:1398-1414
OHSU
Treatment: Comparisons
Morin CM, et al. JAMA 1999;281:991-9
• 8 weeks of: temazepam (7.5-30 mg, avg=20 mg), placebo, CBT-I (8x90 min.), or combination.
• Temazepam increased total sleep time by 43.7 min.
• CBT-I increased total sleep time by 30.5 min. and by 65.2 min. at 2 years
• Combo increased total sleep time by 42.2 min.
• Placebo increased total sleep time by 19.7 min.OHSU
Smith MT et al., Am J Psych. 2002;159:5-11.
Treatment: Comparisons
OHSU
Smith MT et al., Am J Psych. 2002;159:5-11.
Treatment: Comparisons
OHSU
Treatment: Reviews
Buysee JAMA 2013;309: 706-716
OHSU
Treatment: Hypnotic Reviews
Buysee JAMA 2013;309: 706-716
OHSU
Treatment: CBT Reviews
Buysee JAMA 2013;309: 706-716
OHSU
Case
OHSU
OHSU
OHSU
OHSU
OHSU
The EndOHSU
OHSU
Extra SlidesOHSU
Epidemiology
Ohayon M, Sleep Med Rev. 2002;6: 97-111
Morin CM et al., Can J Psych. 2011;56: 540-548
OHSU
Epidemiology
Ohayon M, Sleep Med Rev. 2002;6: 97-111
Morin CM et al., Can J Psych. 2011;56: 540-548
OHSU
Etiology
Reimann et al. Sleep Med Rev 2010;14: 19-31
OHSU
BzRAs: Effects
Walsh JK et al., Sleep. 2000;23:1087-1096.
• Zolpidem, 10mg
vs. Placebo
• 3-5x/week for 8
weeksOHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
OHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists: zolpidem, zaleplon, eszopiclone
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
OHSU
BzRAs: zolpidem ER
• 12.5 mg of zolpidem ER increased total sleep time (sleep diary) by ~110 minutes over 6 months
• Placebo increased total sleep time by ~85 minutes
• Difference of ~25 minutes
Krystal AD et al., Sleep. 2008;31:79-90.
OHSU
BzRAs: benzodiazepines
Glass et al. J Clin Psychopharm 2008; 28: 182-188
• 15 mg of temazepam increased total sleep time (sleep diary) by 1.0 hours over 2 weeks
• Placebo increased total sleep time by 0.4 hours
• Difference of 0.6 hoursOHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
OHSU
Sedating Antidepressants:
Doxepin
Krystal, et al. Sleep 2010; 33:1553-61
• 3 mg of doxepin increased total sleep time (PSG) by 46.8 minutes over 3 months
• Placebo increased total sleep time by 23.1 minutes
• Difference of 23.7 minutesOHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
Gimenez et al. Psychopharm 2007; 190: 507-516
Tassniyom et al. J Med Assoc Thai 2010; 93: 729-34
OHSU
Antipsychotics
• 25 mg of Quetiapine increased total sleep time (sleep diary) by 124.9 minutes over 2 weeks
• Placebo increased total sleep time by 72.2 minutes
• Difference of 52.7 minutes
Tassniyom et al. J Med Assoc Thai 2010; 93: 729-34
OHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
OHSU
Antihistamines:
diphenhydramine
Glass et al. J Clin Psychopharm 2008; 28: 182-188
• 50 mg of diphenhydramine increased total sleep time (sleep diary) by 0.7 hours over 2 weeks
• Placebo increased total sleep time by 0.4 hours
• Difference of 0.3 hoursOHSU
Treatment: Pharmacologic
• Benzodiazepine Receptor Agonists (BzRAs)– Benzodiazepines
– Non-Benzodiazepines GABAA agonists
• Sedating Antidepressants
• Sedating Antipsychotics
• Antihistamines
• Suvorexant (orexin antagonist)
• Gamma-Hydroxybutyrate (GHB)
• Melatonin and Melatonin agonists, Gabapentin, Valerian
OHSU
Orexin antagonist
Michelson et al. Lancet Neurol 2014; 13: 461-471
• Suvorexant (30 or 40 mg) increased total sleep time (sleep diary) by 38.7 minutes over one month
• Placebo increased total sleep time by 16.0 minutes
• Difference of 22.7 minutesOHSU
Orexin antagonist
Sun et al. Sleep 2013;356:259-267
• Suvorexant of 3 different doses, one night PSG
• Placebo total sleep time 440.65 minutes
• Suvorexant total sleep time of up to 461.40 minutes
• Difference of 20.75 minutesOHSU
Laugsand et al., Euro Heart J 2013; 124: 2073-2081
Morbidity/Co-Morbidity: Heart
Failure
OHSU
Treatment: Comparisons
• Similar efficacy pharmocologic vs. cognitive-behavioral
treatments in several studies
• 8 weeks of CBT vs. temazepam (7.5-30 mg) vs. combined
treatment. CBT maintained improved sleep at 3, 12, and
24 months.
• ~6 weeks of CBT vs. zolpidem (5-10mg) vs. combined
treatment. CBT generally better than zolpidem.
Morin CM, et al. JAMA 1999;281:991-9
Jacobs GD, et al. Arch Intern Med 2004;164:1888-1896
Morin CM, et al. Sleep 2006;29:1398-1414
OHSU
Treatment: Comparisons
Jacobs GD, et al. Arch Intern Med 2004;164:1888-1896
• 6 weeks of: zolpidem (10 mg x 4 wks, 5 mg x 1 wk, 5 mg q o night x 1 wk), placebo, or CBT-I (4x30 min. and 1x15 min sessions). Sleep diary (2 weeks).
• zolpidem increased total sleep time by 39.7 minutes after 4 weeks (vs 69.2 minutes after taper)
• CBT-I increased total sleep time by 48.6 minutes
• Placebo increased total sleep time by 29.5 minutesOHSU
OHSU
RADICAL ACCEPTANCE
“Radical Acceptance” means acknowledging what already is.
“Radical Acceptance” doesn’t mean that you like or approve of the situation. It doesn’t mean it’s fair, or the way things “should” be. It doesn’t mean that the situation is any less bad than you think it is.
Radical acceptance simply means that you stop fighting reality.By accepting reality, acknowledging the way things are, we then have a basis for defining what the options are, and making a plan to change the things we have the power to change.
By accepting reality, we can stop wasting energy trying to change the things we cannot change.
Radical acceptance IS difficult – but it’s worth the effort.
Accepting reality can bring us peace of mind, even when the situation is bad.
OHSU
Sensory Processing During
Sleep
Buxton et al., Ann Intern Med. 2012;157: 170-179
OHSU
Sensory Processing During
Sleep
Buxton et al., Ann Intern Med. 2012;157: 170-179
OHSU
Sensory Processing During
Sleep
Buxton et al., Ann Intern Med. 2012;157: 170-179
OHSU
Antidepressant Efficacy
Detke MJ et al., J. of Psychiatric Res. 2002; 36:383-390.
HAM-D17:
8-13 = mild
14-18 = moderate
> 19 = severe -8.3
-10.5
Starting HAM-D17
score of ~20OHSU